Abstract |
Botulinum toxin type A (BTX-A) has been used therapeutically for the treatment of spastic disorders for many years. More recently, the therapeutic utility of BTX-A in the treatment of hyperhidrosis has been recognised. While studies have reported on the efficacy of BTX-A in managing hyperhidrosis, long term data are required in order for the treatment implications to be fully appreciated. We report on a case of severe atrophy of the intrinsic muscles of the hands in a patient treated with intra-palmar BTX-A ( Dysport, Speywood, UK) injections for hyperhidrosis. To our knowledge this has not been described in the literature before.
|
Authors | G E Glass, M Hussain, A N M Fleming, B W E M Powell |
Journal | Journal of plastic, reconstructive & aesthetic surgery : JPRAS
(J Plast Reconstr Aesthet Surg)
Vol. 62
Issue 8
Pg. e274-6
(Aug 2009)
ISSN: 1878-0539 [Electronic] Netherlands |
PMID | 18203669
(Publication Type: Case Reports, Journal Article, Review)
|
Chemical References |
- Neurotoxins
- Botulinum Toxins, Type A
|
Topics |
- Adolescent
- Botulinum Toxins, Type A
(administration & dosage, adverse effects)
- Female
- Humans
- Hyperhidrosis
(drug therapy)
- Injections, Intradermal
- Muscular Atrophy
(chemically induced)
- Neurotoxins
(administration & dosage, adverse effects)
- Treatment Outcome
|